BusinessNonprofit vows to lower generic drug costs By Robert Weisman — Boston GlobeDec. 14, 2015 Reprints Deborah J. Drew (right), chief executive of Drew Quality, chatted with a colleague while Wayne Garcia and Deborah Rhodes went over a report. Matthew Healey for The Boston Globe Nonprofit vows to lower generic drug costs About the Author Reprints Robert Weisman — Boston Globe [email protected] @GlobeRobW Tags drug prices drugs FDA
Business Bob Herman STAT Plus: Wary of changes to Medicare Advantage, health insurers put up a fight — and exaggerate the stakes
Biotech Bob Herman and Damian Garde STAT Plus: Moderna CEO made $398 million in 2022, but still pledges to give most to charity
Health Tech Mohana Ravindranath and Casey Ross STAT Plus: Cerebral and other telehealth startups face new legal and regulatory challenges over ad models
Health Tech Brittany Trang and Casey Ross STAT Plus: ‘We’re getting much more aggressive’: Microsoft’s Nuance adds GPT-4 AI to its medical note-taking tool
A STAT Investigation Casey Ross and Bob Herman STAT Plus: Denied by AI: How Medicare Advantage plans use algorithms to cut off care for seniors in need
